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Baker-Polito Administration Announces Job Creation Incentives for 
23 Massachusetts Life Sciences Companies 
Incentives will create over 1,000 new life science jobs throughout Massachusetts, with 
a focus on small and medium sized companies 
 
BOSTON – Today, the Baker-Polito Administration announced nearly $20 million in 
tax incentive awards to 23 life sciences companies. The awards were approved by the 
Board of Directors of the Massachusetts Life Sciences Center (MLSC), and will create 
over 1,100 new jobs across the Commonwealth in 2018. The tax incentive awards will 
support life sciences job growth in 18 different Massachusetts communities, the 
majority of which are located or expanding outside of Boston and Cambridge. 
 
Governor Charlie Baker announced the awards in his remarks at the BIO 2018 
International Convention, an annual meeting that convenes 16,000 participants 
representing the breadth of the life sciences and application areas including drug 
discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.  
 
“Our administration is committed to supporting strategic investments to create more 
jobs and continue to improve Massachusetts’ overall position as a global leader in the 
 
life sciences,” said Governor Charlie Baker. “We look forward to working with the 
Legislature, MLSC and stakeholders to pass our bill to provide up to $500 million over 
five years for strategic investments in public infrastructure, research and 
development, workforce training and education.” 
 
“We are proud Massachusetts continues to be the world’s leading ecosystem for 
successful life science companies,” said Lieutenant Governor Karyn Polito. “These 
awards support our economic development strategy, and we are pleased to see the 
number of life sciences companies continue to grow across the Commonwealth, 
expanding the reach of our innovation economy to new cities and towns.” 
  
For the 2018 round, MLSC focused on leveraging diverse life sciences assets across 
the state to encourage growth more equitably throughout Massachusetts. Small and 
medium sized enterprises and companies located or expanding outside of Boston and 
Cambridge were actively encouraged to apply to the tax incentive program.  
  
“The Massachusetts Life Sciences Center is an important partner in our work to 
support the growth of Massachusetts economy,” said Housing and Economic 
Development Secretary Jay Ash. “Along with today’s awards, we are working 
together to ensure our students have the skills necessary to join the industry, deepen 
the pool of talent in demand by life sciences companies and ensure Massachusetts 
remains a great place for companies to grow and people to live and thrive.”  
 
“The tax incentive program continues to serve as an example of the Baker-Polito 
Administration’s commitment to job creation throughout Massachusetts,” said 
Administration and Finance Secretary Michael J. Heffernan. “These tax incentives 
serve as a critical catalyst for innovation and growth in this important sector of the 
Massachusetts economy.” 
 
“Through this program we are fulfilling our commitment to supporting an ecosystem 
that fuels job growth, promotes innovation within the industry, and provides a 
constant stimulant for research and development, manufacturing, and 
commercialization in the life sciences,” said Travis McCready, president and chief 
executive officer of the Massachusetts Life Sciences Center. “Moreover, we are 
incentivizing both home grown and global companies to expand their footprint in our 
state.” 
 
The Life Sciences Tax Incentive Program authorizes tax incentives each year for 
growing companies engaged in life sciences research and development, 
commercialization and manufacturing. The primary goal of the program is to 
incentivize life sciences companies of all sizes to create new, long-term jobs in 
Massachusetts. 
  
Through previous award rounds, there are 126 active or completed awards, totaling 
more than $116 million in tax incentives. Prior awardees have created more than 
5,700 new jobs since receiving tax incentives. 
  
“We are pleased to be recognized by the Commonwealth for the ongoing growth of 
our workforce here, and this year we will continue to expand both our physical 
footprint and the types of roles we will bring into the organization with the opening 
of our new clinical development manufacturing plant in Norwood,” said Annie 
Drapeau, chief human resources officer at Moderna Therapeutics. “Massachusetts 
and the companies based here continue to attract the very best talent in our industry, 
and we are excited to be a part of this thriving life sciences community.” 
     
“Berkshire Sterile Manufacturing appreciates the tax incentive award from the 
Massachusetts Life Sciences Center as it allows us to continue to grow and expand in 
Massachusetts,” said Shawn Kinney, PhD, president of Berkshire Sterile 
Manufacturing, Inc. “We continue to add high paying jobs in part from the assistance 
that we receive from MLSC.  Last year we doubled in size and look forward to more 
growth this coming year.” 
  
“We are thankful to receive the tax incentive award from the Massachusetts Life 
Sciences Center,” said Ankit Mahadevia, M.D., chief executive officer of Spero 
Therapeutics.  “The award will assist us as we hire additional employees within the 
local biotech community in Boston to support our mission of bringing novel anti-
infective therapies for current and emerging drug-resistant infections to patients.” 
 
In June 2017, the Baker-Polito Administration filed a legislative proposal to bolster 
Massachusetts’ leadership in the life sciences sector, which would provide up to $500 
million over five years for strategic investments in public infrastructure, research and 
development, and workforce training and education, including up to $295 million in 
capital authorization and up to $150 million in job-creating tax incentives. The 
funding will continue to be managed by the MLSC, which is co-chaired by Housing and 
Economic Development Secretary Jay Ash and Administration and Finance Secretary 
Michael J. Heffernan. 
  
The Tax Incentive Program is jointly administered by the MLSC and the Massachusetts 
Department of Revenue (DOR), which oversees the technical administration of the 
incentives. Jobs that are created must be maintained for at least five years. The Tax 
Incentive Program mandates that awarded companies submit reports and respond to 
inquiries by the MLSC and DOR regarding employment figures. If a company receiving 
a tax incentive under the program does not meet and maintain their minimum 
threshold for job creation, the credit can be recovered by DOR, requiring that the 
company pay back all or a portion of the tax incentives they’ve received. 
  
About the Massachusetts Life Sciences Center 
  
The Massachusetts Life Sciences Center (MLSC) is an economic development 
investment agency dedicated to supporting the growth and development of the life 
sciences in Massachusetts, home to the most verdant and productive life sciences 
ecosystem in the world.  Through public-private funding initiatives, the MLSC 
supports innovation, research & development, commercialization, and manufacturing 
activities in the fields of biopharma, medical device, diagnostics, and digital 
health.  Since its creation in 2007, the MLSC has strategically deployed over $700 
million in Massachusetts, through a combination of grants, loans, capital 
infrastructure investments, tax incentives, and workforce programs.  These 
investments have created thousands of jobs, and propelled the development of new 
therapies, devices, and scientific advancements that are improving patient health and 
well-being in Massachusetts and beyond. 
 
2018 Massachusetts Life Sciences Tax Incentive Program Awardees 
 
Company Location Incentive Amount Jobs 
Abiomed Inc. Danvers $750,000.00  50 
Alkermes, Inc. Waltham $1,500,000.00  100 
Alnylam Pharmaceuticals, Inc. Norton $1,650,000.00  110 
Astellas Institute for 
Regenerative Medicine Marlborough 
$150,000.00  
10 
Berkshire Sterile Manufacturing Lee $340,000.00  23 
Citra Labs, LLC Braintree $450,000.00  30 
Decibel Therapeutics, Inc. Cambridge $200,000.00  22 
EMD Holding Corporation Danvers $1,350,000.00  90 
Enanta Pharmaceuticals, Inc. Watertown $270,000.00 18 
Evelo Biosciences, Inc. Cambridge $465,000.00 31 
Indigo Agriculture, Inc. Charlestown $1,125,000.00 75 
Instrumentation Laboratory 
Company Bedford 
$525,000.00 
35 
Insulet Corporation Acton $3,690,000.00 150 
L.E.A.F. Pharmaceuticals LLC Woburn $300,000.00 20 
Lantheus Medical Imaging, Inc. 
North 
Billerica 
$480,000.00 
32 
Moderna Therapeutics, Inc. Norwood $1,725,000.00 115 
ProTom International Holding 
Corporation Wakefield 
$150,000.00 
10 
Rubius Therapeutics Cambridge $750,000.00 50 
Siemens Healthcare Diagnostics 
Inc. East Walpole 
$2,009 000.00  
82 
Spero Therapeutics, Inc. Watertown $150,000.00 10 
SQZ Biotech Watertown $240,000.00 16 
Vicarious Surgical Inc. Cambridge $150,000.00 10 
WAVE Life Sciences Lexington $1,500,000.00 100 
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